LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹47 Cr | ₹38 Cr | ₹33 Cr | ₹99 Cr | ₹50 Cr |
What is the latest Total Current Liabilities ratio of LYKA LABS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹47 Cr |
| Mar2024 | ₹38 Cr |
| Mar2023 | ₹33 Cr |
| Mar2022 | ₹99 Cr |
| Mar2021 | ₹50 Cr |
How is Total Current Liabilities of LYKA LABS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹47 Cr | 23.45 | |
| Mar2024 | ₹38 Cr | 15.87 | |
| Mar2023 | ₹33 Cr | -67.19 | |
| Mar2022 | ₹99 Cr | 99.18 | |
| Mar2021 | ₹50 Cr | - | |
Compare Total Current Liabilities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹218.8 Cr | -7.2% | -18.7% | -46.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,195.0 Cr | 3% | 9.5% | 3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,849.0 Cr | 1.7% | 3.1% | 5.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,586.0 Cr | 4.7% | 11.7% | 41.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,054.0 Cr | 2.1% | 6.7% | 11.6% | Stock Analytics | |
| CIPLA | ₹108,703.0 Cr | 1.3% | 1.3% | -9.4% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -7.2% |
-18.7% |
-46.6% |
| SENSEX | -1.7% |
0.5% |
8.3% |
You may also like the below Video Courses